Basics of androgen synthesis and action.
Naamneh Elzenaty R, du Toit T, Flück CE.
Best Pract Res Clin Endocrinol Metab. 2022 Jul;36(4):101665. doi: 10.1016/j.beem.2022.101665. Epub 2022 May 6.
Micropenis.
Khadilkar V, Mondkar SA.
Indian J Pediatr. 2023 Jun;90(6):598-604. doi: 10.1007/s12098-023-04540-w. Epub 2023 Apr 20.
Male hypogonadism.
Basaria S.
Lancet. 2014 Apr 5;383(9924):1250-63. doi: 10.1016/S0140-6736(13)61126-5. Epub 2013 Oct 10.
Testomalacia.
Kalra S, Dhingra A, Kapoor N.
J Pak Med Assoc. 2024 Aug;74(8):1545-1546. doi: 10.47391/JPMA.24-61.
Ellagic acid improves benign prostate hyperplasia by regulating androgen signaling and STAT3.
Park WY, Song G, Park JY, Ahn KS, Kwak HJ, Park J, Lee JH, Um JY.
Cell Death Dis. 2022 Jun 17;13(6):554. doi: 10.1038/s41419-022-04995-3.
Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy.
Cai C, Balk SP.
Endocr Relat Cancer. 2011 Aug 30;18(5):R175-82. doi: 10.1530/ERC-10-0339. Print 2011 Oct.
Hermaphroditism pathology.
Jaubert F, Nihoul-Fékété C, Lortat-Jacob S, Josso N, Fellous M.
Rom J Morphol Embryol. 1999-2004;45:41-51.
[Male pseudohermaphroditism].
Fukutani K.
Nihon Rinsho. 1997 Nov;55(11):2920-4.
[Male pseudohermaphroditism].
Isurugi K.
Nihon Hinyokika Gakkai Zasshi. 1994 Aug;85(8):1189-212. doi: 10.5980/jpnjurol1989.85.1189.
Androgen resistance syndromes.
Griffin JE, Leshin M, Wilson JD.
Am J Physiol. 1982 Aug;243(2):E81-7. doi: 10.1152/ajpendo.1982.243.2.E81.
